Stay updated on Elranatamab vs Lenalidomide Post-Transplant Clinical Trial
Sign up to get notified when there's something new on the Elranatamab vs Lenalidomide Post-Transplant Clinical Trial page.
Latest updates to the Elranatamab vs Lenalidomide Post-Transplant Clinical Trial page
- Check4 days agoChange DetectedThe study has added 223 locations including new sites in Los Angeles, California; Maywood, Illinois; Lebanon, New Hampshire; and Gent, Belgium, while removing 244 locations including several in Arizona, Kansas, and Belgium.SummaryDifference15%
- Check11 days agoNo Change Detected
- Check19 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.0%
- Check28 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference0.1%
- Check50 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.0%
- Check57 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study, along with a reference to the Contacts and Locations section.SummaryDifference1%
- Check64 days agoChange DetectedA new study has been added, bringing the total to 244, with details about a site in Madrid, Spain, while a previous study has been removed, reducing the total from 243.SummaryDifference0.4%
Stay in the know with updates to Elranatamab vs Lenalidomide Post-Transplant Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elranatamab vs Lenalidomide Post-Transplant Clinical Trial page.